TrialLancet (London, England)2017

Bortezomib with lenalidomide and dexamethasone versus lenalidomide and dexamethasone alone in patients with newly diagnosed myeloma without intent for immediate autologous stem-cell transplant (SWOG S0777): a randomised, open-label, phase 3 trial.

Brian G M Durie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.